Réaction #45903

ord-4d95ef807d6142039a3b348d991c8850

Équation de réaction

Cc1cc(C(C)(C)C)c(O)c(C(C)(C)C)c1
2,6-di-tert-butyl-paracresol
Cc1c(-c2ccccc2)c(Br)c2oc(C(=O)N(C)C)nc2c1C#N
7-Bromo-4-cyano-N,N,5-trimethyl-6-phenyl-1,3-benzoxazole-2-carboxamide
CCC[CH2][Sn]([CH2]CCC)([CH2]CCC)[C]1=CC(N(C)C(=O)OC(C)(C)C)CC1
tert-butyl methyl-(3-tri-n-butylstannylcyclopent-2-enyl)carbamate
Cc1c(-c2ccccc2)c(C2=CC(CNC(=O)OC(C)(C)C)CC2)c2oc(C(=O)N(C)C)nc2c1C#N
compound
Rendement 88.0%
Cc1c(-c2ccccc2)c(C2=CC(CNC(=O)OC(C)(C)C)CC2)c2oc(C(=O)N(C)C)nc2c1C#N
tert-Butyl {3-[4-cyano-2-dimethylcarbamoyl-5-methyl-6-phenyl-1,3-benzoxazol-7-yl]cyclopent-2-enyl}methylcarbamate
Rendement 88.0%

Solvants

Conditions de réaction

Température
100°CELSIUS
Conditions détaillées
See reaction.notes.procedure_details.

Traitement

  1. 1
    Températurecooled to room temperature
  2. 2
    AutreThe insoluble matter was separated by filtration
  3. 3
    Lavagewith washing with ethyl acetate
  4. 4
    ConcentrationThe filtrate was concentrated under reduced pressure
  5. 5
    AutreThe solvent was evaporated away
  6. 6
    Autrethe resulting residue was purified by middle-pressure liquid chromatography (eluent, n-hexane

Mode opératoire

7-Bromo-4-cyano-N,N,5-trimethyl-6-phenyl-1,3-benzoxazole-2-carboxamide (I-339) (275 mg, 0.72 mmol) and tert-butyl methyl-(3-tri-n-butylstannylcyclopent-2-enyl)carbamate (I-332) (453 mg, 0.93 mol) were dissolved in 1,4-dioxane (8 ml), and at room temperature, 2,6-di-tert-butyl-paracresol (3 mg, 0.01 mmol) and then bis(triphenylphosphine)palladium(II) dichloride (50 mg, 0.07 mmol) were added. The solution was stirred under nitrogen atmosphere at 100° C. for 24 hours, then cooled to room temperature. The insoluble matter was separated by filtration with washing with ethyl acetate. The filtrate was concentrated under reduced pressure. The solvent was evaporated away, and the resulting residue was purified by middle-pressure liquid chromatography (eluent, n-hexane:ethyl acetate=2:1, v/v) to obtain the entitled compound (316 mg, 88%) as a colorless gel.

Source

DOI: 10.6084/m9.figshare.5104873.v1Brevet: US07737166B2uspto-grants-2010_06